515 related articles for article (PubMed ID: 24412457)
1. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
[TBL] [Abstract][Full Text] [Related]
2. A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV study.
Teeuwen K; Adriaenssens T; Van den Branden BJ; Henriques JP; Van der Schaaf RJ; Koolen JJ; Vermeersch PH; Bosschaert MA; Tijssen JG; Suttorp MJ
Trials; 2012 Dec; 13():240. PubMed ID: 23241457
[TBL] [Abstract][Full Text] [Related]
3. The paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: an angiographic follow up study.
Kaul U; Unverdorben M; Degenhardt R; Seth A; Bahl VK; Hiremath SM; Chandra P; Mullesari AS; Sandhu PS; Rao S; George O; Ackermann H; Boxberger M
Indian Heart J; 2013; 65(5):510-7. PubMed ID: 24206873
[TBL] [Abstract][Full Text] [Related]
4. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
[TBL] [Abstract][Full Text] [Related]
5. Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM).
Traynor BP; Fitzgerald S; Alfonso F; O'Kane P; Sabaté M; Tölg R; Trevelyan J; Hahn JY; Mylotte D; Wöhrle J; Rai H; Cortese B; Morice MC; Schuette D; Copt S; Oldroyd KG; Byrne RA;
Cardiovasc Revasc Med; 2023 Nov; 56():75-81. PubMed ID: 37328392
[TBL] [Abstract][Full Text] [Related]
6. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size.
Regar E; Serruys PW; Bode C; Holubarsch C; Guermonprez JL; Wijns W; Bartorelli A; Constantini C; Degertekin M; Tanabe K; Disco C; Wuelfert E; Morice MC;
Circulation; 2002 Oct; 106(15):1949-56. PubMed ID: 12370218
[TBL] [Abstract][Full Text] [Related]
7. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.
Serruys PW; Foley DP; Suttorp MJ; Rensing BJ; Suryapranata H; Materne P; van den Bos A; Benit E; Anzuini A; Rutsch W; Legrand V; Dawkins K; Cobaugh M; Bressers M; Backx B; Wijns W; Colombo A
J Am Coll Cardiol; 2002 Feb; 39(3):393-9. PubMed ID: 11823075
[TBL] [Abstract][Full Text] [Related]
8. Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials.
Cai JZ; Zhu YX; Wang XY; Bourantas CV; Iqbal J; Zhu H; Cummins P; Dong SJ; Mathur A; Zhang YJ
BMJ Open; 2018 Feb; 8(2):e017231. PubMed ID: 29472254
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis.
Iannaccone M; D'Ascenzo F; Templin C; Omedè P; Montefusco A; Guagliumi G; Serruys PW; Di Mario C; Kochman J; Quadri G; Biondi-Zoccai G; Lüscher TF; Moretti C; D'amico M; Gaita F; Stone GW
Eur Heart J Cardiovasc Imaging; 2017 Feb; 18(2):159-166. PubMed ID: 27099274
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Revascularization at 10 Years After Percutaneous Treatment of Drug-Eluting Stent Restenosis.
Koch T; Lenz T; Rheude T; Cassese S; Kazazi M; Xhepa E; Kessler T; Wiebe J; Ferenc M; Laugwitz KL; Joner M; Schunkert H; Kastrati A; Kufner S
JACC Cardiovasc Interv; 2024 Jan; 17(1):1-13. PubMed ID: 37902151
[TBL] [Abstract][Full Text] [Related]
11. Experience with BioMatrix BES and other DES in all-comers setting: a retrospective overview.
Goyal BK; Kalmath BC; Kawar R; Sharma A; Khemnar B; Rangnekar H
Indian Heart J; 2013 Dec; 65(6):678-82. PubMed ID: 24407537
[TBL] [Abstract][Full Text] [Related]
12. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.
Tanabe K; Serruys PW; Grube E; Smits PC; Selbach G; van der Giessen WJ; Staberock M; de Feyter P; Müller R; Regar E; Degertekin M; Ligthart JM; Disco C; Backx B; Russell ME
Circulation; 2003 Feb; 107(4):559-64. PubMed ID: 12566366
[TBL] [Abstract][Full Text] [Related]
13. Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis.
Cui KY; Lyu SZ; Zhang M; Song XT; Yuan F; Xu F
Chin Med J (Engl); 2018 Mar; 131(5):600-607. PubMed ID: 29483397
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients.
Giacoppo D; Gargiulo G; Aruta P; Capranzano P; Tamburino C; Capodanno D
BMJ; 2015 Nov; 351():h5392. PubMed ID: 26537292
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus-eluting stent treatment for unprotected versus protected left main coronary artery disease in widespread clinical routine: 6-month and 3-year clinical follow-up results from the prospective multicentre German Cypher Registry.
Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Neumann FJ; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Richardt G;
Heart; 2007 Oct; 93(10):1251-5. PubMed ID: 17890701
[TBL] [Abstract][Full Text] [Related]
16. The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions.
Holmes DR; Lansky A; Kuntz R; Bell MR; Buchbinder M; Fortuna R; O'Shaughnessy CD; Popma J
Am J Cardiol; 2000 Nov; 86(10):1073-9. PubMed ID: 11074202
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis.
Meng M; Gao B; Wang X; Bai ZG; Sa RN; Ge B
BMC Cardiovasc Disord; 2016 Feb; 16():34. PubMed ID: 26860585
[TBL] [Abstract][Full Text] [Related]
18. Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes.
Marino BC; Nascimento GA; Rabelo W; Marino MA; Marino RL; Ribeiro AL
Arq Bras Cardiol; 2015 May; 104(5):375-86. PubMed ID: 25651344
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
